FDA Adverse Event Summary report: N

VOCO PROFLUORID VARNISH

MDR report key: 6154096 · Received December 8, 2016

Report

Report Number
8010908-2016-00002
Date Received
December 8, 2016
Date of Event
August 30, 2016
Report Date
December 8, 2016
Manufacturer
VOCO GMBH
Product Code
LBH
PMA / PMN Number
K080814
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
DENTIST

Narratives

Additional Manufacturer Narrative · 1

AN INVESTIGATION OF THE PRODUCT IN QUESTION COULD NOT BE PERFORMED. THE PRODUCT WAS NOT RETURNED TO US. LOT-NUMBER AND EXPIRY DATE ARE UNKNOWN. THE CASE WAS ASSIGNED TO THE DEPARTMENT OF COMPLAINTS AND DOCUMENTED. NO FURTHER MEASURES ARE PLANNED ON THIS CASE. COLOPHONY-INTOLERANCES CANNOT BE EXCLUDED, ESPECIALLY FOLLOWING APPLICATION TO EXTENSIVE SURFACES LIKE THIS CASE. THE INSTRUCTIONS FOR USE CONTAIN APPROPRIATE WARNINGS. (B)(4).

Description of Event or Problem · 1

THE (B)(4) AGENCY HAS RECEIVED A REPORT FROM A (B)(6) HEALTHCARE PROVIDER REGARDING AN INCIDENT WITH VOCO PROFLUORID VARNISH. THE INCIDENT CONCERNS A PATIENT WITH SIDE EFFECTS SUCH AS SWELLING AND ITCHING AFTER TREATMENT WITH PROFLUORID VARNISH. THE MEDICAL PRODUCTS AGENCY REQUESTS U.S. TO SUBMIT A VIGILANCE REPORT FROM THE MANUFACTURER TO THE MEDICAL PRODUCTS AGENCY IN ACCORDANCE WITH (B)(4) REGULATION. VOCO PROFLUORID VARNISH IS MARKETED IN U.S. ;THEREFORE, THE EVENT IS REPORTABLE ACCORDINGLY 21CFR 803. INCIDENT DESCRIPTION RECEIVED BY DENTIST: DENTIST TREATED THE PATIENT WITH FLUORIDE VARNISH GENERALLY, ON EVERY TOOTH ON THE 30/8. A WEEK LATER, HIS MOTHER WAS AT THE CLINIC AND TOLD HIM THAT THE BOY HAD AN ALLERGIC REACTION IN THE EVENING/NIGHT AND REACTED WITH ITCHING/SORE/SWELLING IN THE MOUTH AND ON THE LIPS. THE PARENTS COULD NOT CONNECT THE REACTION TO ANYTHING ELSE BUT THE FLUORIDE VARNISH. THE PATIENT IS FULLY RECOVERED. THERE IS NO SEVERE MEDICAL IMPLICATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
806871 VOCO PROFLUORID VARNISH VOCO PROFLUORID VARNISH LBH VOCO GMBH

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization